BM

Brandywine Managers Portfolio holdings

AUM $104M
1-Year Est. Return 28.94%
This Quarter Est. Return
1 Year Est. Return
+28.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$104M
AUM Growth
+$3.62M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
39
New
Increased
Reduced
Closed

Top Buys

1
+$751K
2
+$565K
3
+$546K
4
KVYO icon
Klaviyo
KVYO
+$120K
5
VKTX icon
Viking Therapeutics
VKTX
+$111K

Top Sells

1
+$559K
2
+$403K
3
+$330K
4
NVO icon
Novo Nordisk
NVO
+$259K
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$228K

Sector Composition

1 Technology 49.28%
2 Healthcare 10.81%
3 Financials 0.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PD icon
26
PagerDuty
PD
$1.11B
$504K 0.48%
30,517
KVYO icon
27
Klaviyo
KVYO
$8.77B
$481K 0.46%
17,384
+4,346
BEAM icon
28
Beam Therapeutics
BEAM
$2.71B
$452K 0.43%
18,606
SDGR icon
29
Schrodinger
SDGR
$1.31B
$419K 0.4%
20,886
OKTA icon
30
Okta
OKTA
$15.2B
$386K 0.37%
4,209
-6,100
VKTX icon
31
Viking Therapeutics
VKTX
$4B
$323K 0.31%
12,301
+4,219
GPCR icon
32
Structure Therapeutics
GPCR
$1.92B
$310K 0.3%
11,057
MRNA icon
33
Moderna
MRNA
$9.84B
$246K 0.24%
9,510
TWLO icon
34
Twilio
TWLO
$19.4B
$236K 0.23%
2,357
TXG icon
35
10x Genomics
TXG
$2.26B
$221K 0.21%
18,938
RLAY icon
36
Relay Therapeutics
RLAY
$1.36B
$201K 0.19%
38,429
ABCL icon
37
AbCellera Biologics
ABCL
$1.04B
$143K 0.14%
28,488
NVO icon
38
Novo Nordisk
NVO
$211B
– –
-3,747
S icon
39
SentinelOne
S
$5.68B
– –
-10,501
1
2